{"id":"nbp608","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Limited public information is available regarding the specific mechanism of action for NBP608. As a phase 3 candidate from SK Chemicals, it represents an advanced-stage investigational drug, but detailed mechanistic data has not been widely disclosed in accessible pharmaceutical databases or literature.","oneSentence":"NBP608 is a novel therapeutic agent in development by SK Chemicals, currently in phase 3 clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:50:19.945Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07415252","phase":"PHASE3","title":"SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years","status":"NOT_YET_RECRUITING","sponsor":"SK Bioscience Co., Ltd.","startDate":"2026-06-05","conditions":"Varicella (Chickenpox)","enrollment":780},{"nctId":"NCT03114943","phase":"PHASE3","title":"Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age","status":"COMPLETED","sponsor":"SK Bioscience Co., Ltd.","startDate":"2016-07-14","conditions":"Varicella","enrollment":516},{"nctId":"NCT03121638","phase":"PHASE1","title":"Safety Study of NBP608 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2012-11","conditions":"Varicella Zoster, Immunization; Infection","enrollment":150},{"nctId":"NCT03120364","phase":"PHASE3","title":"Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2015-09-09","conditions":"Herpes Zoster","enrollment":824},{"nctId":"NCT03116594","phase":"PHASE2, PHASE3","title":"Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2014-01-03","conditions":"Herpes Zoster","enrollment":675},{"nctId":"NCT03114982","phase":"PHASE2","title":"The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2016-05","conditions":"Varicella","enrollment":152}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NBP608","genericName":"NBP608","companyName":"SK Chemicals Co., Ltd.","companyId":"sk-chemicals-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":3,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}